AzTrials
AzTrials

StrokeNCT05375578

Urdu Translation of Wayfinding Questionnaire for Stroke Patients

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Descriptive analytical study to translate WQ in Urdu Language. The WQ is in English Language the name of the author of WQ is Van der Ham Et al and firstly introduced in 2013. The reliability of this English tool is 0.70 to 0.80 it has been translated in various Languages i.e Hungarian, Dutch and Chinese and suffering… Read more about this study

Who is it for?
Ages 45 to 65 years
Conditions the study is for
Stroke
How many people
70 participants
Where
1 sitePakistan
Study dates
15 May 2021to 30 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: stroke

Who may be able to join

  • Age group 45-65 years
  • Male and Female.
  • Both ischemic and hemorrhagic stroke
  • Patient may have First or Recurrent Stroke.
  • Recovery is > 6 months of First Stroke event
  • MMSE score > 25

Who cannot join

  • Population suffering from Severe Global Aphasia.
  • Population suffering from Severe Mobility Problem.
  • Any other neurological disease dementia
  • Alzheimer's
  • Cognitive Decline before Stroke

Trial locations and contacts

1 site in 1 country.

Pakistan1 site

  • Hospital

    Lahore, Pakistan(Punjab_, 54000

Other trials in Pakistan

About this study

Official title: Urdu Translation and Cross Cultural Validation of Wayfinding Questionnaire for Stroke Patients

Descriptive analytical study to translate WQ in Urdu Language. The WQ is in English Language the name of the author of WQ is Van der Ham Et al and firstly introduced in 2013. The reliability of this English tool is 0.70 to 0.80 it has been translated in various Languages i.e Hungarian, Dutch and Chinese and suffering from stroke. But it was not translated in Urdu Language. No such study has been previously conducted in Pakistan region which translates the scale and follows the proper cross-cultural adaptation

Read the detailed description

For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items dated from 01 to 07 in which stroke patients are accessed. The patients who are taken in the study age from 18 to 65 years. As the WQ is a well-developed measurement scale for accessing navigation in stroke patients. It is meaningful to validate its Urdu version. The translation and cultural adaptation process would start after obtaining approval from the developer of the original WQ. This would be done according to bitten guidelines. The purpose will be to gain uniformity in the translation of both the target Language and source Language. This will involve 5 steps which is forward translation, synthesis 1, back translation, synthesis 2 and pallet testing. The second step would be done according to the Beaton guidelines in which psychometric properties will be measured that is internal consistency, test retest reliability, Discriminant validity, Convergent Validity, Content Validity and Factor analysis

Conditions
Stroke
Keywords
Way finding Questionnaire, Navigation, Cognition.
Medical subject headings
Stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wayfinding Questionnaire

    For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items rated from 1 to 7 in which stroke patients are assessed. The patients who are taken in the study age from 45 to 65 years.

    Measured: 8 months

Secondary outcomes (2)

  1. Reliability of translated version of WQ

    To determine the reliability of cross-culturally adapted and translated WQ in the patients with stroke.

    Reliability or reproducibility reference to a measure to produce the same results when administered at to intervals between different visits of the patients. Thus this will be measured through test re-test reliability

    Measured: 8 months

  2. Validity of translated version of WQ

    To determine the validity of cross-culturally adapted and translated WQ for stroke patients in Urdu language

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2022
  2. Study start15 May 2021
  3. Primary completion15 Jul 2022
  4. Study completion30 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05375578
Sponsor's protocol ID
REC/Lhr/22/0207 Suhair Asif
Status last verified
Dec 2022
First submitted
28 Apr 2022
Last updated
12 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hamre C, Fure B, Helbostad JL, Wyller TB, Ihle-Hansen H, Vlachos G, Ursin MH, Tangen GG. Impairments in spatial navigation during walking in patients 70 years or younger with mild stroke. Top Stroke Rehabil. 2020 Dec;27(8):601-609. doi: 10.1080/10749357.2020.1755814. Epub 2020 Apr 21.

    PubMed 32316862

  • de Rooij NK, Claessen MHG, van der Ham IJM, Post MWM, Visser-Meily JMA. The Wayfinding Questionnaire: A clinically useful self-report instrument to identify navigation complaints in stroke patients. Neuropsychol Rehabil. 2019 Aug;29(7):1042-1061. doi: 10.1080/09602011.2017.1347098. Epub 2017 Jul 18.

    PubMed 28720024

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wayfinding Questionnaire (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05375578, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2022.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in